Assessing the Potential Risk of Cross-Reactivity Between Anti-Bococizumab Antibodies and Other Anti-PCSK9 Monoclonal Antibodies.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/8406FFFD.svg?ark=w1%2F20260526%2F8406FFFD&value=id)](https://nobleid.org/work/w1/20260526/8406FFFD)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors